We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: PathoKey MP UTI ID and AMR PCR test detects UTI Pathogens and Antimicrobial resistance genes (Photo courtesy of Pexels)

Multiplex PCR-Based Test Detects UTI Pathogens and Antimicrobial Resistance Genes

A new multiplex PCR-based test allows for the in vitro detection and differentiation of 14 pathogens that cause urinary tract infections (UTI), as well as 14 antimicrobial resistance (AMR) genes encoding resistance to five antibiotics, all in one run. More...
23 May 2022
Image: EsoGuard has demonstrated over 90% specificity and 90% sensitivity in identifying Barrett’s Esophagus (Photo courtesy of Lucid Diagnostics)

Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer

A new technology coupled with a new biomarker test are giving patients timely access to a quick, accurate and less invasive way to identify risk for Barrett's esophagus (BE). More...
23 May 2022
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. More...
20 May 2022
Image: Accurate, non-invasive, inexpensive blood test will help diagnose bowel cancer early (Photo courtesy of Swansea University)

Revolutionary Blood Test to Transform Early Diagnosis of Bowel Cancer

An accurate, non-invasive, inexpensive blood test can diagnose bowel cancer early and dramatically cut waiting times for diagnosis while reducing the need for unnecessary invasive procedures such as colonoscopies. More...
20 May 2022
Image: Mass spectrometry shown well-fit to detect key markers of Alzheimer’s (Photo courtesy of Pexels)

Mass Spectrometry Could Enable Early Prediction of Alzheimer’s Disease from Blood Samples

Research has confirmed that new mass spectrometry (MS)-based technologies can help better understand the pathogenesis of Alzheimer’s disease (AD), diagnose it at early stages, predict risks, and create more effective therapeutic approaches. More...
20 May 2022
Image: Molecular profiling of diseased joint tissue can predict response to arthritis treatment (Photo courtesy of QMUL)

Study Identifies Molecular Signatures in Arthritis Patients for Incorporation In Diagnostic Tests

New research has shown that molecular profiling of the diseased joint tissue can significantly impact whether specific drug treatments will work to treat rheumatoid arthritis (RA) patients. The incorporation of these molecular signatures in future diagnostic tests will be a necessary step to translate these findings into routine clinical care. More...
20 May 2022
Image: Biosensor technology could enable direct and sensitive analysis of clinical samples at POC (Photo courtesy of Unsplash)

Biosensor Technology Could Pave Way for POC Diagnosis of Cancer, Pathogens, and Other Diseases

Researchers have developed a biosensor using a method to generate nanostructured and nanoporous surfaces. This combined strategy not only provides the sensor with an unprecedented sensitivity but also makes it resistant to fouling by proteins. More...
19 May 2022
New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Pipette Calibration System
Artel PCS®


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.